The precise mechanism of the
acantholysis after
pemphigus IgGs bind to
desmoglein (Dsg) 3 and/or Dsg 1 on the cell surface is as yet unknown. We have previously reported that
pemphigus IgG (P-
IgG) causes a transient increase in intracellular
calcium and
inositol 1,4,5-trisphosphate concentration, and subsequent activation of
protein kinase C (PKC) in DJM-1 cells, a
squamous cell carcinoma line. In order to see whether
phosphatidylcholine (PC)-specific
phospholipase C (PLC) or
phospholipase D (
PLD) is involved in the P-
IgG-induced signaling process, the production of
1,2-diacylglycerol (DAG) and
phosphatidylbutanol (PBut), a potential marker for the determination of
PLD activity in the presence of
butanol, was determined in DJM-1 cells. A biphasic accumulation of DAG, which consisted of a first transient phase and a second sustained phase, was observed. The second phase of DAG accumulation was profoundly inhibited by pretreatment with
D609, a selective inhibitor of
PC-PLC, but not by
propranolol, an inhibitor of
phosphatidate phosphohydrolase.
Pemphigus serum after preadsortion of
antibodies to Dsg 3 and Dsg 1 with recombinant Dsg 3 and Dsg 1 did not show formation of DAG. PBut was not generated following the addition of P-
IgG. In addition, the levels of [3H]
phosphocholine, a direct metabolite of
PC-PLC, were elevated after the addition of P-
IgG. These results suggest that the
PC-PLC pathway plays a major role in P-
IgG-induced transmembrane signaling by causing prolonged generation of DAG, which may lead to long-term activation of PKC.